Introduction {#s1}
============

Women live for longer than do men in most modern societies ([@bib43]) but suffer from higher levels of morbidity later in life ([@bib1]; [@bib4]). Sex differences in health during aging are underpinned by differences in patterns of decline in the structure and function of specific tissues. For example, the gut ages differently in men and women, such that many gastrointestinal diseases and cancers are gender-biased ([@bib15]; [@bib32]; [@bib30]). However, the mechanisms underlying sex differences in intestinal pathology are not well understood.

Females of the fruit fly *Drosophila melanogaster* show substantial gut pathology during aging, which limits female lifespan ([@bib7]; [@bib45]; [@bib58]). *Drosophila* are mostly post-mitotic as adults, but the gut contains intestinal stem cells (ISCs) ([@bib37]; [@bib38]), and their division drives age-related intestinal hyperplasia ([@bib6]; [@bib17]). Epithelial barrier function declines during aging, and its failure is predictive of death ([@bib47]; [@bib20]). However, it is not known to what extent males suffer from intestinal pathology during aging; indeed, studies of aging in male *Drosophila* are generally less common ([@bib36]; [@bib40]; [@bib54]), and little is known about tissue-specific sexual dimorphisms in aging phenotypes ([@bib9]; [@bib14]; [@bib35]). Interestingly, *Drosophila* females show a much greater longevity response to dietary restriction (DR) than do males ([@bib36]), although the role of the gut in this sex difference has not been investigated.

We have uncovered substantial sexual dimorphism in the incidence of gut pathology during aging, with females showing widespread deterioration in epithelial structure and loss of gut barrier function, while males generally maintain both even at very late ages. However, males succumbed to oral bacterial infections to which females were resistant, with female guts containing a higher number of proliferating cells, suggesting a trade-off between gut plasticity and/or repair mechanisms, and old age pathology in females. Gut pathology in aging females was ameliorated by DR, suggesting that the greater response of female lifespan to DR may be a consequence of improved gut function. Taking advantage of cell autonomous sex determination in *Drosophila*, we produced males that had a region of the midgut genetically feminized and we found that this region alone showed the female pattern of aging-related pathology and increase in mitotic stem cells. Furthermore, these feminized males also showed a greater increase in lifespan in response to DR, comparable to that seen in females. Males demonstrated higher age-related, systemic inflammation compared to females, and sensitivity to oral bacterial infection, indicative of immune dysfunction, despite better maintenance of gut barrier function. Intriguingly, this points to further sex bias(es) in immunity that could contribute to male mortality.

Results {#s2}
=======

Sex differences in age-related gut pathologies {#s2-1}
----------------------------------------------

ISC division becomes dysregulated with age, leading to a hyperplastic intestinal pathology. ISC over-proliferation and a build-up of undifferentiated enteroblasts (EBs) lead to cell crowding and eventual tumor formation ([@bib6]; [@bib17]; [@bib41]). In order to better understand the effect of these events for intestinal epithelial organization, we subjected guts from outbred, wild type females and males with labeled epithelia (*w^Dah^;Resille-GFP*) to high-resolution imaging over the entire adult lifespan at weekly intervals.

Several recent studies have shown the *Drosophila* gut to be highly regionalized in function, cell type and gene expression ([@bib13]; [@bib21]; [@bib56]). We therefore analyzed four gut regions, identifying them with high fidelity ([Figure 1A](#fig1){ref-type="fig"}). These were the proventriculus (PV), midgut region 2 (R2) and midgut regions 4--5 (R4/R5), spanning most of the length and functional diversity of tissues in the adult midgut. Young females showed a well-organized PV, with a honeycomb arrangement of tightly packed cells forming the outer wall ([Figure 1B--D](#fig1){ref-type="fig"}), arranged in a columnar epithelium with perfectly aligned nuclei ([Figure 1E--G](#fig1){ref-type="fig"}). In all distal midgut regions, large, polyploid, absorptive, enterocytes (ECs) were aligned to form a single layer epithelium with evenly spaced nuclei ([Figure 1H--M](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). ISCs were nested at intervals along the basal side of the gut ([Figure 1K--M](#fig1){ref-type="fig"}) and were mitotically active as visualized by phosphohistone H3 (PH3) immunostaining ([Figure 2J](#fig2){ref-type="fig"}).10.7554/eLife.10956.003Figure 1.Intestinal stem cell activity produces severe epithelial pathology in females.(**A**) Outline of the adult gut indicating specific regions and areas subjected to image analysis (orange dashed boxes). (**B-D'**) Surface (**B**) and corresponding zoom (**C-D'**) of the proventriculus (PV) from 7-day (**B-D**) and 42-day (**C'**,**D'**) --old females. Zoom panels show the green (epithelium; *Resille-GFP*) and blue (nuclei; DAPI) channels separately. Yellow arrowheads denote wound rosettes (**C'**) and yellow asterisks denote multinucleated cells (**C'**,**D'**). (**E-G'**) Central section of the PV (E) and corresponding zoom panels (**F-G'**) in 7-day (**E-G**) and 42-day (**F'**,**G'**) --old females. Yellow arrowheads denote extra, tumor-like cells in the epithelium (**I'**) and yellow asterisks denote their corresponding nuclei (**J'**). (**H-J'**) Surface of the gut at R2 (**H**) and zoom panels (**I-J'**), at 7days (**H-J**) and 42 days (**I'**,**J'**). Yellow arrowheads denote small, tumor-like cell clusters. (**K-M'**) Luminal section at R2 (**K**) and zoom panels (**L-M'**). Yellow arrowhead denotes basal ISC (**L**,**M**). (**N-R'**) pathology in very old (70 day-old) females: PV surface (**N**) and corresponding zoom (**O**); R2 surface (**P**) and corresponding zoom (**O'**). (**Q-R'**) R4 section and corresponding zoom. Zoom panels (**R**,**R'**) have had their colors inverted to better visualize tumor nuclei.**DOI:** [http://dx.doi.org/10.7554/eLife.10956.003](10.7554/eLife.10956.003)10.7554/eLife.10956.004Figure 1---figure supplement 1.Epithelial pathology in females.PV at 21 days, section and surface, an example of intermediate pathology (cat III). R4 at 7 days and 42 days for comparison. R4 pathologies here include epithelial holes and tumors. PV, proventriculus.**DOI:** [http://dx.doi.org/10.7554/eLife.10956.004](10.7554/eLife.10956.004)10.7554/eLife.10956.005Figure 2.Females have more severe age-related intestinal pathologies than males.(**A-D**) Young (7 day-old) male and female flies had comparable epithelial organization in the PV (**A**,**B**), but at old age (42 days) only females showed epithelial pathology (**C**,**D**). For R2 region, see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. (**E-H**) Females raised on a high-yeast diet developed a more severe pathology than males by 42 days (**G**,**H**). (**I**) PV pathologies were binned into scaled categories, where I = WT undisrupted honeycomb, II = loss of regularity in epithelial cell size and pattern; few (\<5) rounded unpolarized cells on apical side. III = sporadic wound healing rosettes and/or 5--10 apical cells; IV = widespread rosettes and/or \>10 apical cells; V = severe pathology including holes, scars and tumors. Low yeast females tended to have less pathology than high yeast females (n=12 guts per condition, ordinal logistic regression, OLR; p=0.07) (**J-L**) Female flies had more actively dividing ISCs than males, visualized by anti-pH3+ immunostaining. Images from R5 in 35-day-old flies are presented (**J**,**K**); quantification of pH3+ cells per gut demonstrated that females had more mitoses than males at 35 days (n=20 guts per sex; student's *t* test, p \< 0.001) (**L**). (**M-N**) Barrier function was compromised in old females but not males. 'Smurf' flies with leaky intestines (M) were present in female, but not male cohorts of *w^D^;Resille* flies at 42 days (n≥150 flies per condition, representative of three repeated experiments, Fisher's exact, p = 0.008) (**N**). (**O-P**) Males succumbed to oral infection with the gram-negative bacterium *Erwinia carotovora (Ecc*) at 35 days, whereas females were resistant (**O**). PH3+ cell number per gut was increased in females (n≥10 per condition; student's *t* test, p = 0.0042) and males (p = 0.0003) upon *Ecc* oral infection. More mitoses were induced in female compared to male guts (p = 3.6E-05) (**P**). (**Q-T**) AMPs and ROS were higher in challenged and unchallenged males compared to females. *Diptericin* expression was higher in both sham- and *Ecc*-infected males, compared to females at 35 days (n≥3 samples per condition, 10 individuals pooled per sample, 2 technical repeats; *t* test with Welch's correction, p = 0.0135 for sham, p = 0.0012 for infected) and was upregulated significantly upon infection in males (p = 0.0132), and tended to be higher after infection in females (p = 0.0571) (**Q**). *Duox* expression was not upregulated after infection in 35-day-old males or females (n≥3 samples per condition, 10 individuals pooled per sample, 2 technical repeats; *t* test with Welch's correction, p = 0.8639 for females, p = 0.2303 for males), but was higher in males than females overall (p = 0.0060 for sham, p= 0.0793 for infected) (**R**). Systemic *diptericin* was higher in males than females and increased with age in males (n≥3 samples per condition, 10 individuals pooled per sample, 2 technical repeats; *t* test with Welch's correction, p = 0.0062 for 7-day-old females vs males; p = 0.0158 for 42-day-old females vs males; p = 0.2435 for 7-day-old vs 42-day-old females; p = 0.0003 for 7-day-old vs 42-day-old males) (**S**). *Duox* expression did not increase with aging in either sex, but expression was higher in males than females at both 7 and 42 days (n≥3 samples per condition, 10 individuals pooled per sample, 2 technical repeats; *t* test with Welch's correction, p = 0.0029 for 7-day-old females vs males; p = 0.0206 for 42-day-old females vs males; p = 0.4531 for 7-day-old vs 42-day-old females; p = 0.4857 for 7-day-old vs 42-day-old males (**T**). Males had a lower aerobic bacterial load than females at 21 days, (n≥8 samples per condition, 5 individuals pooled per sample; Wilcoxon test, p = 0.05) (**U**). A similar result was obtained for anaerobic load.**DOI:** [http://dx.doi.org/10.7554/eLife.10956.005](10.7554/eLife.10956.005)10.7554/eLife.10956.006Figure 2---figure supplement 1.Females have more severe age-related intestinal pathologies than males.Examples of the R2 region in females and males on low- and high- yeast diets at 7 days and 35 days for comparison. Both surface and luminal section images are presented. In females at 35 days, groups of stem cells can be seen on the surface which are associated with multiple layered nuclei in luminal sections. Females on high-yeast food often presented a more severe pathology than those on low-yeast diets.**DOI:** [http://dx.doi.org/10.7554/eLife.10956.006](10.7554/eLife.10956.006)10.7554/eLife.10956.007Figure 2---figure supplement 2.Sex differences in pathology, barrier dysfunction and response to intestinal challenge.(**A**) Pathology at 64 days in *w^D^;Resille* males and females. Categories are described in [Figure 2](#fig2){ref-type="fig"} legend. Males show significantly less pathology than females in all regions (n≥16 per group; ordinal logistical regression analysis, p\<0.00000001 for PV, p\<0.01 for R2, p\<0.001 for R4). (**B-C**) Analysis of barrier dysfuction; at 80 days in *w^Dah^* did not identify Smurf phenotype in males (n≥80 per group, Fisher's exact, p\<0.01) (**B**); at 42 days in *w^1118^* identified the Smurf phenotype in a small proportion of males, but significantly more females (n≥200 per group, Fisher's exact, p\<0.01) (**C**). (**D**) Lifespan analysis of female (red) and male (blue) *w^Dah^* flies on two different yeast dilutions. Females live longer than males on both diets (mean lifespans: female 1SYA = 68.2, male 1SYA = 51.6, female 2SYA = 63.7, male 2SYA = 50.7. Log rank; 1SYA, p=1.3E-26; 2SYA, p=1.34--20). Females live longer on 1SYA than 2SYA (Log rank, p=0.0088), but male lifespan is not extended on 1SYA compared to 2SYA (p=0.37) (**E**) 30-day-old males and females were exposed to DDT by feeding for 18 hr and total deaths were scored. By 18 hr, the majority of males had died (83%; red). Compare to females where most survived (2.7% dead; Fisher's exact, p\<0.0001) (G). PV, proventriculus**DOI:** [http://dx.doi.org/10.7554/eLife.10956.007](10.7554/eLife.10956.007)

In aging females, disruptions to the PV epithelium began to appear at between 2 and 3 weeks of age, with rounded, unpolarized cells clustering apically ([Figure 1F'-G'](#fig1){ref-type="fig"}). This abnormality was progressive ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), and eventually led to tumor formation. The effect of this hyperplasia on the basal side of the PV epithelium was marked; cells were pulled away from the basal edge due to tumor formation or apoptosis, leading to the appearance of rosettes characteristic of epithelial wound healing ([Figure 1C'](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). These wounds became more numerous until, at very late ages, the epithelium did not heal properly, resulting in the formation of large scars, holes and multinucleated cells ([Figure 1C'-D', N-O](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). R2 and R4 regions also showed dramatic aging phenotypes driven by an accumulation of small nuclei cells on the basal side - ISCs and EBs - which disrupted the single layer and eventually led to tumor formation and loss of epithelial organization ([Figure 1I',J',L',M',O'-R'](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Strikingly, aged males showed only a low incidence of pathology in both the PV and midgut ([Figure 2A--H](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Indeed, many males in the oldest cohorts examined (up to 64 days post-eclosion) had well-maintained intestinal epithelia ([Figure 2---figure supplement 2A](#fig2s2){ref-type="fig"}). For example, outer wall cells of the PV were maintained as a single layer columnar epithelium with well-aligned nuclei ([Figure 2B,D,F,H](#fig2){ref-type="fig"}). The R2 midgut region retained regular spacing of ECs with few ISCs nested between them, similar to young guts ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Aged males had far fewer PH3-positive cells in the midgut when compared to females ([Figure 2J--L](#fig2){ref-type="fig"}), suggesting that ISCs were largely quiescent. To determine whether this sex difference in ISC activity and epithelial integrity was reflected in barrier function, we fed aging *w^Dah^* females and males a blue dye that normally does not traverse the gut ([@bib47]), at 42 days and 80 days, and scored flies that leached dye into the body cavity ('Smurfs'). A low, but consistent, proportion of Smurfs was found in old females, while males never produced Smurfs, even in the oldest (80 day-old) cohorts ([Figure 2M--N](#fig2){ref-type="fig"}, [Figure 2---figure supplement 2B](#fig2s2){ref-type="fig"}). This is striking given the maximum lifespan for males (final surviving 10% of the population) is 64 days ([Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). A recent study, describing the Smurf technique, found that the inbred laboratory strain *w^1118^* does produce male smurfs, but at a lower rate than females ([@bib47]). We confirmed this, finding a small proportion of *w^1118 ^*male smurfs (\<2%) at 42 days ([Figure 2---figure supplement 2C](#fig2s2){ref-type="fig"}).

Males are more susceptible to intestinal infection and xenobiotic stress {#s2-2}
------------------------------------------------------------------------

While dysregulated ISC division may be detrimental at older ages (e.g. [@bib7]), ISC responsiveness to gut damage maintains intestinal homeostasis and promotes survival in young females ([@bib12]; [@bib16]).

We hypothesized that males, which have fewer ISCs and with a lower basal rate of division ([@bib31]; this study), would be more susceptible to intestinal stress such as oral infection, compared to females. The bacterium *Erwinia carotovora (Ecc)* induces antimicrobial peptide (AMP) expression and ISC division in the midgut when ingested ([@bib5]; [@bib3]) but is not usually lethal to healthy adult females ([@bib27]). When we challenged aged females and males with oral infection by *Ecc*, we found that females were resistant to the infection. However, a high proportion of males succumbed after around 72 hr ([Figure 2O](#fig2){ref-type="fig"}). Upon analysis of the ISC response to *Ecc* infection, we found that infected female midguts had a significantly higher number of actively dividing (PH3+) cells at 18-hr post-infection compared to controls. Although male midguts also responded to infection, the overall number of mitotic cells was significantly lower than in infected females ([Figure 2P](#fig2){ref-type="fig"}). In addition, when we exposed flies to a xenobiotic agent in their food (DDT; [@bib50]), female flies were significantly more resistant to this challenge ([Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}). These findings suggest that, despite the patent hyperplastic pathology, older females are more resilient to intestinal challenge than are males. This sex bias may, in part, be promoted by higher numbers of dividing ISCs in females, despite this being detrimental to the maintenance of epithelial integrity at older ages.

Although repair of the epithelium is an important trait for survival during intestinal stress, other factors will also contribute. We therefore assessed the systemic response to *Ecc* oral infection in aged males and females. *Diptericin* (*dipt*, an antimicrobial peptide \[AMP\] responsive to gram-negative infection sensed by the Imd pathway), was expressed at higher levels in unchallenged males compared to females, and was strongly upregulated upon infection in males ([Figure 2Q](#fig2){ref-type="fig"}). This high systemic *dipt* did not induce a high survival rate for males, many of which later succumbed to the infection, and may instead be indicative of an infection not effectively contained by the gut and/or a sepsis-like response. To better understand inflammatory status during aging in females and males, we measured expression of *dipt* during aging. Only males showed increased expression of *dipt* as they aged and, at both ages, males expressed *dipt* at a significantly higher level than did females ([Figure 2S](#fig2){ref-type="fig"}). We also analyzed expression of the ROS-producer *dual oxidase* (*duox*) at young and old ages. *Duox* is expressed in immune-active epithelia, especially the gut, and is necessary for survival to foodborne pathogens ([@bib27]). *Duox* levels did not change significantly during aging, but males had higher expression than did females at both ages ([Figure 2T](#fig2){ref-type="fig"}). This suggests that, even in the absence of acute infection, males suffer from a higher level of systemic inflammation than do females, despite better maintenance of gut barrier function.

The sex differences in gut pathology and systemic inflammation could affect the bacterial load in the intestinal microbiota, which could in turn affect pathology and inflammation. We therefore analysed internal bacterial load in females and males at 21 days, and found that females had a higher load than did males ([Figure 2U](#fig2){ref-type="fig"}). Higher bacterial load in the gut correlated with the higher levels of dysfunction and pathology observed in females compared to males ([@bib47]; [@bib11]; [@bib20]), and suggests that factors apart from total load, such as specific composition of the microbiota ([@bib11]; [@bib20]), or infection through other routes ([@bib25]), may explain the increased systemic *dipt* in males.

Female intestinal pathologies are ameliorated by DR {#s2-3}
---------------------------------------------------

ISC division is regulated by both diet and nutrient sensing IIS ([@bib18]; [@bib7]; [@bib39]). DR of dietary protein can extend lifespan in a wide range of animals ([@bib34]; [@bib49]; [@bib23]; [@bib51]). When we analyzed the guts of flies fed on two different yeast dilutions, we found that pathology was lower in old females that had been exposed to the low-yeast diet ([Figure 2C,G,I](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), in line with studies showing that ISC division ([@bib18]; [@bib39]) and intestinal barrier dysfunction ([@bib47]) are reduced in females on restricted diets. Male flies, however, derived no obvious benefit to intestinal morphology from DR, largely because very little pathology was evident in males, even on a high-yeast diet ([Figure 2D,H,I](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

Males with feminized midguts develop female-like intestinal pathology {#s2-4}
---------------------------------------------------------------------

Sex determination in fruit flies is cell autonomous, with X-chromosome counting leading to a cascade of splicing events and expression of sex-specific transcription factors ([@bib48]). We exploited this cell autonomy, by mis-expressing the female-specific spliceform of *transformer (UAS-tra^F^*) in male flies, using the midgut driver *NP1-Gal4* ([@bib60]), to achieve midgut-specific feminization. We then analyzed the effect on intestinal pathology during aging.

Cell size is larger in female flies than in males, in all tissues ([@bib2]; [@bib24]). Accordingly, males with feminized midguts had larger ECs compared to control males ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). Quantitative PCR on dissected guts demonstrated that *doublesex (dsx^F^*), the direct downstream target of *tra^F^* ([@bib33]), was expressed in feminized male guts at high levels ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). As further proof-of-principle for sex reversal, we expressed *UAS-tra^F^*in whole flies using the ubiquitous driver *da-Gal4*, producing transgendered males that were feminized in all sexually dimorphic structures ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}).10.7554/eLife.10956.008Figure 3.Feminized male guts develop female-like intestinal pathologies.(**A-G**) Mis-expression of *tra^F^* feminizes male midguts. (**A-F"**) PV (**A-B"**) and R2 (**C-F"**) morphology in *+/tra^F ^*females (**A-F**), *+/tra^F ^*males (**A'-F'**) and *NP1\>tra^F^* males (**A"-F"**) at 7 and 35 days, reveal female-like pathology in the R2 region of *NP1\>tra^F^* males at 35 days (**F"**). The *NP1* driver is not expressed in the majority of the PV and accordingly, the PV is well-maintained at 35 days (**B"**). Control females and feminized males increased ISC proliferation over age, but control males did not (n=10--20 guts per condition, student's *t* test, p=0.0366 for 3 vs 35 day-old *+/tra^F^*females, p=0.0015 for 3 vs 35 day-old *NP1\>tra^F^* females, p=0.7057 for 3 d vs 35 d *+/tra^F^*males, p=0.00022 for 3 vs 35 day-old *NP1\>tra^F ^*feminized males). Feminized male guts (*NP1\>tra^F^*) had more mitoses at 35 days than control (*+/tra^F^*) male guts (p=0.00018) (**G**). (**H-J**) barrier dysfunction and systemic AMP expression were increased in feminized males. Barrier dysfunction was significantly higher in feminized males than control (*+/tra^F^*) males at 42 days (n≥150 per group, Fisher's exact, p=0.0001) and control (*+/tra^F^*) females (p=0.0002) (**H**). *Diptericin* expression was increased over aging in all genotypes (n≥3 samples per condition, 10 individuals pooled per sample, 2 technical repeats; 2-way ANOVA, age p=0.0487, condition p=0.1031, interaction p=0.3485) and was increased in feminized males relative to control males at 7 days only (*t* test with Welch's correction, p=0.0018 for *NP1\>tra^F^*vs *+/NP1* at 7 days; p=0.5152 for *NP1\>tra^F^*vs *+/NP1* at 42 days; p=0.0011 for *NP1\>tra^F^*vs *+/tra^F^* at 7 days; p=0.8907 for *NP1\>tra^F^*vs *+/tra^F^* at 42 days) (**I**). *Doux* expression did not increase over aging in any genotype, but was higher in males than females overall (**J**). (**K**) Aerobic bacterial load tended to increase between 7 and 21 days for both sexes and genotypes (n≥8 samples per condition, 5 individuals pooled per sample; Monte Carlo Markov Chain Generalised Linear Model with Poisson Error Family, where *pMCMC*=0.040 for males and *pMCMC*=0.064 for females). Feminized males had a significantly higher load than control males (*pMCMC*\<0.001). In addition, the direction of bias compared to females was switched in feminized males, such that control males had lower load than females, but feminized males had a higher load. A similar result was obtained for anaerobic load. (**L-N**) Pathologies in feminized males are responsive to diet and rapamycin treatment. Pathologies were binned into scaled categories and quantified, n≥12 per condition. PV categories as described in [Figure 2](#fig2){ref-type="fig"} legend (see [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"} for PV scoring). R2 and R4 categories were defined as follows: I = WT, single layer epithelium with low number of basal ISCs. II = sporadic pathology of small nuclei 'nests' without significant disruption to the epithelium; III = widespread pathology, majority of epithelium has several layers of nuclei; IV = widespread pathology plus clear tumor formation. Gut feminized males have significantly worse pathology than control males on both diets in R2 (OLR, low-yeast, z=-3.916, p=0.0000899; high-yeast z=-4.339, p=0.0000143) and R4 (low-yeast, z=-4.012, p=0.0000602; high-yeast z=-4.520, p=0.0000617). The incidence of severe pathology and tumors (cat IV) in R2 was greater in feminized males than control females on high yeast diet (p=0.04) but not low yeast diet (p=0.48), suggesting that there was a cost of feminization that was partly alleviated by DR (**L-M**). Rapamycin treatment decreased mitoses in females and feminized males at 16 days (n≥10 guts per condition, students *t* test; control (*+/tra^F^*) females, p=0.0079; control (*+/tra^F^*) males, p=0.1; control females (*NP1/tra^F^),* p=0.22; feminized males (*NP1/tra^F^),* p=0.0001). (**N**) **O-R** Feminized males were more sensitive to oral infection, but acquired a lifespan response to dietary restriction. At 42 days males succumbed to *Ecc* oral infection while females did not. Feminized males died significantly sooner than controls (**O**). After *Ecc* oral infection at 7 days, males and females of all genotypes increased gut mitoses compared to sham infected (n≥10 guts per condition, students *t* test; control (*+/NP1*) females, p=2.082E-06; control (*+/NP1*) males, p=0.0011; control females (*NP1/tra^F^),* p=0.00017; feminized males (*NP1/tra^F^),* p=0.00045). However, females and feminized males lost the response to infection against a background of high proliferation in unchallenged individuals at 42 days (n≥10 guts per condition, students *t* test; control (*+/NP1*) females, p=0.2; control (*+/NP1*) males, p=0.0088; control females (*NP1/tra^F^),* p=0.1478; feminized males (*NP1/tra^F^),* p=0.2344) (**P**). Systemic *dipt* expression was increased after 18 hr continuous infection in all genotypes at 42 days (n≥10 guts per condition, *t* test with Welch's correction; *+/NP1* females, p=0.0571; *+/NP1* males, p=0.0132; *+/tra^F ^*females, p=0.0376; *+/tra^F ^*males, p=0.0282; *NP1/tra^F ^*females, p=0.0110; *NP1/tra^F^* feminized males p=0.0331), but at a higher level in males than females in both sham and infected conditions (sham: *+/NP1* females vs males, p=0.0135; *+/tra^F^* females vs males, p=0.0428; *NP1/tra^F ^*females vs males, p=0.0022. Infected: *NP1/+* females vs males, p=0.0012; *+/tra^F^* females vs males, p=0.0964; *NP1/tra^F ^*females vs males, p=0.0237.) (**Q**). Lifespan analysis of *NP1\>tra^F^*males and *+/NP1* control males and females on two yeast dilutions. *NP1\>tra^F^* males were significantly shorter lived than control males on both standard (low yeast; log rank, p=0.0023) and double (high yeast; log rank, p=2.06E-11) yeast dilutions, whereas *+/NP1* control males did not differ between food conditions (log rank, p=0.34). This is a representative lifespan of three with similar outcomes. Cox proportional hazards analysis of the lifespan demonstrated a significantly increased risk of dying on high-yeast vs low-yeast food overall (p=2 x 10--16), and a significant difference in the response to food between control male genotypes and *NP1\>tra^F^* (gut feminized) males (p=0.0298). For full analysis, see [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}. PV, proventriculus.**DOI:** [http://dx.doi.org/10.7554/eLife.10956.008](10.7554/eLife.10956.008)10.7554/eLife.10956.009Figure 3---source data 1.Output table for Cox Proportional Hazards analysis of the *NP1\>tra^F^* (feminized gut) lifespan ([Figure 3Q](#fig3){ref-type="fig"}), showing hazard ratios, *z* and p values, and significance for all interactions.**DOI:** [http://dx.doi.org/10.7554/eLife.10956.009](10.7554/eLife.10956.009)10.7554/eLife.10956.010Figure 3---figure supplement 1.Feminization by misexpression of *tra^F^*.(**A-C**) Misexpression of *tra^F^* feminized males. Enterocyte cell size was greater in control females (*w^D^;+/UAS-tra^F^,Resille-GFP; tra^F^/+*) than control males (student's *t* test, p=0.003), and was increased in 7-day-old feminized male (*w^D^;NP1-Gal4/UAS-tra^F^,Resille-GFP; NP1\>tra^F^*) guts, compared to control male guts (student's *t* test, p=0.005) (**A**). The female-specific form of *doublesex (dsx^F^*), the direct downstream target of *tra^F^*, was expressed at higher levels in the midguts of *NP1\>tra^F^* compared to control *tra^F^/+* male guts (student's *t* test, p=0.037) by quantitative PCR. Expression in *NP1\>tra^F^* feminized males was approx. Two fold higher than in control *tra^F^/+* females (student's *t* test, p=0.05) and *NP1\>tra^F^* females (student's *t* test, p=0.04). NB *tra^F^/+* and *NP1\>tra^F^* females expressed comparable levels of *dsx^F^* (student's *t* test, p=0.263), suggesting feedback regulation of *dsx^F^*expression in females (**B**). Males flies were feminized in sexually dimorphic structures by ubiquitous mis-expression of the female-specific isoform of transformer (*UAS-tra^F^*), using the *daughterless-Gal4 (da-Gal4*) driver. Feminized males (*da/tra^F^*) partially regained female stripe pattern on the posterior dorsal cuticle, had feminized genitalia and loss (red asterisk) of sex combs (red arrow) (**C**).**DOI:** [http://dx.doi.org/10.7554/eLife.10956.010](10.7554/eLife.10956.010)10.7554/eLife.10956.011Figure 3---figure supplement 2.Feminized males increase mitoses but do not resist oral *Ecc* infection.(**A**) The driver *NP1-Gal4* was not expressed at high levels in the PV. Accordingly, pathologies did not appear in the PV in *NP1\>tra^F^* males, where control females developed worse pathologies than feminized males (z=-2.182, p=0.0291). (**B**) Analysis of midgut mitoses. pH3+ cell number was increased in *NP1\>tra^F^* midguts at 35 days, compared to control *tra^F^/+* males (student's *t* test, p=1.52E-05). There was a higher number of mitoses in high-yeast *tra^F^/+* females (student's *t* test, p=0.033) compared to low yeast. *NP1\>tra^F^* males did not increase mitoses on high yeast (means; low yeast = 18.7, high yeast = 20.7; p=0.6). (**C**) Control males and females (*NP1/+* and *tra^F^*/+) do not differ in mitoses per gut at 35 days (n=10, students *t* test, p=0.956 for females and p=0.601 for males). (**D-E**) Survival to oral infection at 7 days (**D**). Survival to oral infection at 42 days showing all controls (**E**) (**F-G**) Average feeding on normal and infected food. Feminized males (*NP1\>tra^F^*) do not feed differently from control males on normal food (n=8 groups of five individuals, students *t* test, *NP1\>tra^F^* males vs control males: *NP1/+* 1SYA (low yeast) p=0.352, 2SYA (high yeast) p=1; *tra^F^*/+ 1SYA p=0.272, 2SYA p=0.852) (**F**). No significant differences between sexes, or between sham and infected (with students *t* test) (**G**). (**H**) Full *NP1\>tra^F^* lifespan with all controls (see [Figure 3](#fig3){ref-type="fig"} legend and [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"} for statistical analyses).**DOI:** [http://dx.doi.org/10.7554/eLife.10956.011](10.7554/eLife.10956.011)

We analyzed intestinal aging in gut-feminized males (*w^D^;NP1-Gal4/UAS-tra^F^,Resille-GFP; NP1\>tra^F^*) and found that age-related pathologies were apparent at 35 days post-eclosion, whereas male control flies (*w^D^;+/UAS-tra^F^,Resille-GFP; +/tra^F^*) generally had well-maintained guts at this age. Pathology in the feminized guts was comparable to that seen in females, or more severe ([Figure 3A--F"](#fig3){ref-type="fig"}). The *NP1-Gal4* driver is expressed throughout the midgut from R1, but only in a small number of cells in the PV ([@bib60]), serving as a useful internal control. Accordingly, the PV in *NP1\>tra^F^* males did not develop age-related pathologies ([Figure 3A--B"](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). PH3-positive cell number was dramatically increased in aged *NP1\>tra^F^* males compared to control males, as predicted by the observed pathologies ([Figure 3G](#fig3){ref-type="fig"}). When we analyzed barrier dysfunction in these flies, we found that at 42 days, gut-feminized males produced significantly more flies with a Smurf phenotype than control males (who produced none) and control females ([Figure 3H](#fig3){ref-type="fig"}). Feminized males presented a high level of systemic *dipt* expression ([Figure 3I](#fig3){ref-type="fig"}) and *Duox* expression ([Figure 3J](#fig3){ref-type="fig"}) at young and old ages. In addition, when we analyzed aerobic and anaerobic bacterial load at 7 and 21 days, we found that load increased with age as previously reported (e.g. [@bib11]; [@bib20]). Importantly, while load in control females was higher than in males, this trend was switched in feminized males, who had a higher load than did females of the same genotype ([Figure 3K](#fig3){ref-type="fig"}).

To investigate whether midgut homeostasis in feminized males was responsive to diet, we raised *NP1\>tra^F^* flies on two different yeast dilutions. Similar to females, feminized males on the high-yeast diet appeared to show a more severe pathology at 35 days than did those on low yeast ([Figure 3L--M](#fig3){ref-type="fig"}). In line with this, when we analyzed the rate of tumor formation (category IV) in a specific region of the gut (R2), we found that DR significantly decreased the risk of tumor formation in feminized males ([Figure 2L](#fig2){ref-type="fig"}). The observed pathologies demonstrate that female and feminized ISCs respond to DR, however, when we quantified PH3+ cell number in 35 day-old guts, although female high-yeast guts had more mitoses, this difference was not significant in feminized males ([Figure 3---figure supplement 2B](#fig3s2){ref-type="fig"}). One possible explanation is that the observed pathology is an accumulation of ISC activity, which could expose subtle differences in mitotic rate over a lifetime. Another possibility is that ISC division and pathology are linked but pathology is driven by other factors that are responsive to diet, such as changes to the microbiota ([@bib20]; [@bib42]). The TOR pathway inhibitor rapamycin extends lifespan in females, and to a much lesser extent in males ([@bib8]), and a recent study showed that it decreases ISC division and slows barrier dysfunction in females ([@bib22]). When we treated males, females and feminized males with rapamycin, we found that ISC proliferation and gut pathology were reduced in females and feminized males ([Figure 3N](#fig3){ref-type="fig"}). This shows that, similarly to DR, females derive a greater benefit from rapamycin than do males, possibly explaining, at least in part, the sex bias in the magnitude of lifespan extension by the drug.

Feminized males are not more robust to oral infection, but their lifespan responds to DR {#s2-5}
----------------------------------------------------------------------------------------

To assess whether the acquired ISC activity in gut-feminized males could contribute to a more robust survival to intestinal stress, we challenged them to *Ecc* oral infection at 7 and 42 days of age. At 5-days post-infection, 7-day-old females and males survived, but approximately 50% of gut-feminized males had died ([Figure 3---figure supplement 2D](#fig3s2){ref-type="fig"}). Analysis of ISCs post-infection showed that feminized males induced significantly higher proliferation than control males, but this was clearly not protective ([Figure 3P](#fig3){ref-type="fig"}). In aged (42 day-old) flies, as before, we found that only males succumbed to *Ecc* oral infection. Feminized males were most susceptible, dying more quickly than did control males ([Figure 3O](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2E](#fig3s2){ref-type="fig"}), and this was not related to a change in feeding on either normal food ([Figure 3---figure supplement 2F](#fig3s2){ref-type="fig"}) or the infection pellet ([Figure 3---figure supplement 2G](#fig3s2){ref-type="fig"}). At this age, female guts had a high number of mitoses, but these did not significantly increase on infection, and nor did they in feminized males ([Figure 3P](#fig3){ref-type="fig"}). One interpretation of this result is that, in aged females and feminized males, the pool of ISCs has been exhausted by continued mitotic activity through the lifespan, or that due to age-related triggers such as inflammation or dysbiosis, ISC activity is already at a maximum. Markedly different to females, however, was the high induction of systemic *dipt* in control and feminized males ([Figure 3Q](#fig3){ref-type="fig"}), in line with their reduced survival. Altogether, these data show that age-related sensitivity of males to intestinal infection was not rescued by feminization of the midgut. One probable contributing factor to the high death rate of feminized males is the barrier dysfunction observed at 42 days ([Figure 3H](#fig3){ref-type="fig"}). However, their sensitivity to *Ecc* at young ages points to other, compromised immune responses. We hypothesize that a sex mis-match between the gut and other immune tissues such as the fat body and hemocytes, may be detrimental.

Females show a greater lifespan extension than do males when subjected to DR ([@bib36]). Males from the outbred line *w^Dah^* used in this study have a mean lifespan that is 22 days shorter than that of their female siblings' ([Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}), and only females showed a lifespan extension when raised on food with a 50% reduction in yeast ([Figure 2---figure supplement 2D](#fig2s2){ref-type="fig"}). Comparison of the lifespans of gut-feminized males with control female and male flies raised on a standard diet showed that gut-feminized males were significantly shorter lived than control males ([Figure 3R](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2H](#fig3s2){ref-type="fig"}), suggesting that their acquired intestinal hyperplasia was detrimental to their lifespan. Interestingly, when we measured the responses of lifespan to two different yeast dilutions, we found that midgut-feminized males had acquired a response to DR similar in magnitude to that seen in control females ([Figure 3R](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2H](#fig3s2){ref-type="fig"} and [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). Taken together with our data on tissue sex and gut pathology, this finding suggests that lowered levels of intestinal pathology contribute to increased female longevity upon DR, and offers one explanation for the difference between males and females in the response of their lifespans to diet.

Discussion {#s3}
==========

In marked contrast to the gut pathology previously reported in aging females ([@bib6]; [@bib17]; [@bib41]), and the extensive deterioration seen in multiple regions of the gut in the present study, we found that males generally have well-maintained guts into old age, even at ages close to the maximum male lifespan. Female intestinal pathology is driven by stem cell activity ([@bib41]), which is responsive to diet ([@bib18]; [@bib39]). Gut hyperplasia is limiting for female lifespan: when ISC division is genetically reduced, female lifespan is extended ([@bib7]; [@bib29]; [@bib46]; [@bib55]). We showed that, by switching the sexual identity of male midgut cells, ISC activity was increased, pathologies appeared and lifespan was shortened. In addition, the lifespan of males with feminized guts became responsive to diet, with DR both reducing the risk for developing severe pathology and increasing lifespan. The marked sexual dimorphism in gut pathology during aging provides a potential explanation for why males do not increase lifespan as much as do females in response to DR. Because males do not suffer from age-related hyperplasia, they do not derive the same benefit from DR-induced stem cell quiescence. Limited hyperplasia could also at least partly explain the much greater increase in lifespan seen in females than in males upon reduced IIS ([@bib19]; [@bib53]); given that ISC activity in females is responsive to insulin signaling ([@bib7]; [@bib39]; [@bib29]).

Intestinal barrier function decreases during aging in females, and this decline is associated with an increase in immune activation, a decrease in nutrient absorption and death ([@bib47]). We showed that sustained ISC division has drastic consequences for the female gut epithelium, causing scars and holes to appear on the basal side. Interestingly, in transcriptomic analysis of aging guts of flies raised in both natural and axenic conditions, genes involved in wound healing were increased during aging ([@bib26]). In line with the absence of severe pathology in males, barrier function was maintained into old age. Despite this, males succumbed to oral infection and xenobiotic stress to which females were resistant, and this sensitivity was not rescued by feminization. We found that the gut ISC response to infection, a repair process, was significantly lower in male flies and increased in feminized males. Regulation of ISC activity is therefore not the only difference between males and females affecting resistance: other epithelial immune responses such as ROS and antimicrobial peptide production or tolerance to *Ecc*-derived toxins could also be sexually dimorphic ([@bib57]). The male sensitivity and sepsis-like response to *Ecc* oral infection, age-related systemic inflammation and high levels of ROS production shown in this study are striking and present a starting point for the analysis of sex differences in intestinal immunity, which will be relevant for resistance to opportunistic infection and shaping the microbiome.

Intestinal plasticity is important not only to resist infection ([@bib12]), but also to respond predictively to the increased energy demands of egg production upon mating ([@bib44]), which could explain why females and males invest so differently in ISC activity. Male reproduction does not require the same amount of nutritional input and, therefore, large-scale intestinal remodeling would probably not increase reproductive rate, which is promoted instead by increased detection and courtship of females ([@bib10]). This sex difference is evolutionarily conserved, in that female mammals extensively grow and remodel their guts, increasing digestive and absorptive capacity in accordance with the increased nutritional demands of lactation ([@bib28]; [@bib52]). Possibly related to this greater gut plasticity, women have higher rates of region-specific colon cancer than do men ([@bib32]; [@bib30]), although the mechanisms underlying this difference are not well understood. Female-specific intestinal remodeling during reproduction could be a driving factor. Intriguingly, higher parity and earlier childbearing are protective against colon cancer, whereas later child-bearing is a significant risk factor ([@bib59]), suggesting that the timing of reproductive events may affect ISC (mis-)regulation. Further studies linking early gut plasticity, nutrition and fecundity with severity of hyperplastic pathology during aging in *Drosophila* may help elucidate conserved mechanisms underlying sex differences in cancer rates.

Materials and methods {#s4}
=====================

Fly strains {#s4-1}
-----------

All mutants were backcrossed for six generations into the wild type, outbred strain, *w^Dahomey^*(*w^Dah^*), maintained in population cages. The following fly stocks were obtained from the Bloomington Stock Centre: *P{UAS-tra.F}20J7, P{GawB}Myo31DF^NP0001^*(referred to as *NP1-Gal4*), and *daughterless-Gal4. P{PTT-un1}CG8668^117-2^ (Resille-GFP)* was originally obtained from the Flytrap project and was a gift from A Jacinto.

Fly husbandry {#s4-2}
-------------

Stocks were maintained and experiments conducted at 25°C on a 12 hr:12 hr light:dark cycle at 60% humidity, on food containing 10% (w/v) brewer's yeast, 5%(w/v) sucrose, and 1.5% (w/v) agar unless otherwise noted (referred to as 'low yeast' food denoting an arbitrary 1:1 sugar to yeast ratio, which is changed to 1:2 (20% yeast, 5% sucrose) for 'high yeast' food). For measurement of gut histology and lifespans, flies were reared at standard larval density and eclosing adults were collected over a 12-hr period. Flies were mated for 48 hr before being sorted into experimental vials at a density of 10 flies per vial. Flies were transferred to fresh vials thrice weekly, and for lifespan, deaths/censors were scored during transferral.

Imaging of gut pathology {#s4-3}
------------------------

Guts were dissected from live flies in ice-cold PBS and immediately fixed in 4% formaldehyde for 15 min. Guts were mounted in mounting medium containing DAPI (Vectastain) and endogenous GFP was imaged immediately. Between 6 and 14 guts were analyzed per condition, per time point. Images were captured with a Zeiss (UK) LSM 700 confocal laser scanning microscope using a 40x oil-immersion objective.

Immunohistochemistry {#s4-4}
--------------------

The following antibodies were used for cell division analyses; primary antibodies: rabbit anti-PH3 (Cell Signaling (Danvers, MA) 9701) 1:500; mouse anti-GFP (Cell Signaling 2955) 1:1000. Secondary antibodies: Alexa Fluor 594 donkey anti-rabbit ((A21207) Thermo Fisher Scientific, Waltham, MA) 1:1000; Alexa Fluor 488 donkey anti-mouse (A21202) 1:1000. Guts were dissected in ice cold PBS and immediately fixed in 4% formaldehyde for 15 min, serially dehydrated in MeOH, stored at -20°C, and subsequently stained. Guts were washed in 0.2% Triton-X / PBS, blocked in 5% bovine serum albumin / PBS, incubated in primary antibody overnight at 4°C and in secondary for 2 hr at RT. At least 10 guts per condition were mounted, scored and imaged as described above.

Gut barrier analysis (Smurf assay) {#s4-5}
----------------------------------

Gut barrier efficiency was analyzed by placing flies on blue food (minimum 110 flies per condition, except at 80 d, min. 80 flies) prepared using using 2.5% (w/v) FD&C blue dye no. 1 (Fastcolors) as previously described ([@bib47]), except flies were kept on the blue food for 24 hr before the Smurf phenotype was scored.

Oral infection survival assay {#s4-6}
-----------------------------

At least 3 x colonies of *Ecc15* were grown in separate overnight cultures in Luria-Bertani medium, pooled, pelleted and adjusted to OD^600^ = 200 with fresh LB. Bacteria were mixed 1:1 with 5% sucrose (final OD^600^ = 100); LB / sucrose was used for sham infection. Flies were starved for 5 hr in empty vials. Experimental vials were lined with 10 pieces of Whatman filter paper to which 1 ml *Ecc15* / sucrose (or LB / sucrose) was added. Starved flies were added at a density of 20/vial; a minimum of 80 flies/condition. Filter paper was refreshed each day with newly grown *Ecc15* / sucrose (or LB / sucrose) solutions, using a Pasteur pipette. Deaths were scored thrice daily.

DDT ingestion survival assay {#s4-7}
----------------------------

Ten flies per vial, at least 110 flies per condition, were fed with the organochloride dichlorodiphenyltrichloroethane (DDT; Supelco, Sigma-Aldrich, UK) for 18 hr. To standard SYA food, 0.03% (w/v) DDT, made from a stock solution of 2% (w/v) DDT in ethanol, was added. Deaths were scored thrice daily.

Feeding assay {#s4-8}
-------------

Flies were transferred to vials at a density of 5 per vial on the evening before the assay. Vials were coded and placed in a randomized order on viewing racks at 25°C overnight. The assay occurred with minimal noise and physical disturbance. Thirty minutes was allowed between the arrival of the observer and commencement of the assay. Observations were performed blind for 90 min, 1 hr after lights-on. Vials were observed for approximately 3 s during which the number of flies feeding was noted. A feeding event was scored when a fly extended its proboscis and made contact with food. Successive rounds of observations were carried out giving an observation rate of once / 5 min. Feeding data are expressed as a proportion by experimental group (sum of scored feeding events divided by total number of feeding opportunities, where total number of feeding opportunities = number of flies in vial×number of vials in the group×number of observations). For statistical analyses, comparisons between experimental groups were made on total feeding events by all flies within a vial, to avoid pseudoreplication.

Bacterial load measurements {#s4-9}
---------------------------

As described for guts ([@bib11]), whole flies were surface sterilized for 1 min in 95% ethanol, rinsed and pooled into groups of 5, n≥8 per condition, on ice for homogenization. Three 1/5 serial dilutions were plated on Man, Rogosa and Sharpe (MRS) plates and cultured at 29^°^c both aerobically and anaerobically, and scored at 48 and 72 hr.

Gut cell size measurements {#s4-10}
--------------------------

Nearest-neighbour internuclear distance in the R2 region was measured from raw LSM files (Zeiss) using the Measure function in Fiji (Image J); 20 distances per gut, n ≥ 6 guts per condition.

RNA isolation and quantitative RT-PCR analysis {#s4-11}
----------------------------------------------

RNA was isolated from n ≥ 14 guts per sample with TRIzol (Invitrogen, Thermo Fisher Scientific, Waltham, MA) and cDNA was synthesized by using SuperScript II Reverse Transcriptase (Invitrogen) according to manufacturers instructions. qPCR was carried out by using Power SYBR Green PCR Master Mix (Thermo Fisher Scientific) on QuantStudio6 Flex real-time PCR (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA). The following primer sequences (Eurofins, UK) were used in the analysis: *dsxF-*F (TCAACACGTTCGCATCACAAA); *dsxF-*R (TAGACTGTGATTAGCCCAATAACTGA), *act5C*-F (CACACCAAATCTTACAAAATGTGTGA); *act5C*-R (AATCCGGCCTTGCACATG); *dipericin*-F (GCGGCGATGGTTTTGG); *dipericin*-R (CGCTGGTCCACACCTTCTG); *Duox*-F (TAGCAAGCCGGTGTCGCAATCAAT); *Duox*-R: ACGGCCAGAGCACTTGCACATAG.

Statistical analyses {#s4-12}
--------------------

Statistical analyses were performed in Excel (Microsoft) or Prism (Graphpad, La Jolla, CA), except for Ordinal Logistical Regression (OLR), Cox Proportional Hazards and Monte Carlo Markov Chain Generalised Linear Model with Poisson Error Family analyses, which were performed in R (using the clm function from the \'ordinal\' library for OLR). Statistical tests used are indicated in the figure captions. Outliers were rarely excluded from the data, but when excluded conformed to the rule of lying more than two standard deviations away from the mean. They are clearly marked as data points on graphical displays.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Sex difference in pathology of the ageing gut mediates the enhanced response of female lifespan to dietary restriction\" for peer review at *eLife*. Your submission has been favorably evaluated by Sean Morrison (Senior editor) and three reviewers, one of whom, Andrew Dillin, is a member of our Board of Reviewing Editors, and another is David Walker.

The reviewers have discussed the reviews with one another and the Reviewing editor has drafted this decision to help you prepare a revised submission.

The physiological differences to explain lifespan differences among the sexes is poorly understood. Using the fruit fly *Drosophila* melanogaster, Regan and colleagues correlate certain aspects of gut plasticity to fly aging in males vs. females. Increased intestinal stem cell division found in females is correlated with shorter lifespan compared to the division rate in males. By converting male intestines to a female state, the authors can shorten male lifespan and change the response to dietary restriction.

In general, the reviewers appreciated the work and potential impact of the work. However, there was unanimous agreement that better analysis of the gut during aging is needed as well as analysis of other parameters of gut functions, such as anti-microbial defense systems and antioxidant systems.

The following major points were found across all three reviews:

1\) More careful analysis of gut function breakdown during aging is required. While all reviewers agree with the analysis of ISC proliferation, more detailed and later timepoints need to be performed, especially in the case of male lifespan. Please consider Reviewer \#3's statements about other correlates.

2\) Do the microbiota change in males vs. females, especially given the genetic alteration of male flies with a feminized gut. While it is agreed that a complete study of the microbiota is beyond the scope of this study, could a cursory analysis be completed to test if gross changes are observed? The same holds for dysbiosis.

3\) Data is provided for the lifespan effects on feminized guts of males, but infection by *Ecc* is not. Please test. Additionally, because this is a lifespan shortening effect, the authors need to control for strain sickness. One idea is to test another longevity paradigm that is not sex modified.

4\) Throughout the text references are lacking or misplaced and prior work in this area is not discussed sufficiently.

5\) Appropriate driver controls for all experiments need to be presented.

Reviewer \#1:

In general this is a very interesting set of observations that corroborate several observations in the fly aging field. Sex specific differences in fly lifespan have been reported, yet a causal mechanism has been elusive. Here, the authors have investigated gut \"function\" during aging and find that female guts tend to attempt repair and proliferation more than male guts. While females are more resistant to toxins ingested (such as *Erwinia carotovora* infection), their guts deteriorate faster. Accordingly, diet restriction appears to preserve gut function in aged female flies. In male flies, feminizing parts of the intestine creates dysplasia and now makes the males responsive to DR, albeit the transgenic males are already short-lived.

Overall, the study is well performed and the interpretation of the existing data is good. However, there are a few points that should be addressed.

The issue of microbiota playing a role in males vs. females should be analyzed. Is there a huge difference and can this be reversed in the feminized males?

The lifespan analysis: showing that DR can make a sick strain more healthy is nice, but is it specific as stated? Is there a different lifespan extending paradigm that is not sex specific that can be tested? If so, does it increase longevity of the feminized animals?

Some analysis of the feminized animals has been carefully performed. One piece lacking is the resistance to *Ecc* infection or other toxin (DDT) treatment. Are the feminized males now resistant?

Reviewer \#2:

In general, I find the paper and findings interesting. The physiological origins of sex differences in longevity are poorly understood. The major strength of the paper is the data showing that male flies with feminized guts show \'female-like\' pathology and show an improved lifespan response upon DR. My major concern, however, is that some of the claims of the paper are overstated and not fully supported by the data. Another issue regards the novelty of the findings and, perhaps more importantly, the authors not giving credit to previous work where credit is due.

Major issues:

Novelty:

The Edgar lab reported in Cell. 2009 Jun 26;137([@bib7]):1343-55 that male guts show greatly reduced turnover rates compared to females.

The Walker lab reported in PNAS 2012 109([@bib55]):21528-33 that diet restriction delays intestinal pathology in female flies.

In the current manuscript, the authors build upon and extend both of these findings. But, they do not cite the preceding work. Citing the previous work doesn\'t harm the current paper. In fact, it strengthens the claims of the paper.

Claims of the paper not supported by the data:

In both the Abstract and first line of the Discussion it is claimed that:

Abstract: \"male flies die with their guts largely unaffected by ageing\"

Discussion: \"male flies maintain a phenotypically perfect gut until death\".

However, this claim is not supported by the data in paper. In order to support such a claim, the authors would need to examine gut pathology in a large number of male flies in the days (hours?) preceding death. Referring to [Figure 2](#fig2){ref-type="fig"}, in the text, the authors state that \'many\' male flies show no intestinal pathology up to 70d of age. I am missing this data. In the figures, I only see data up to 42 days of age.

How many male flies were tested? What ages? How many 70d old male flies showed \'gut pathology\'? How many didn\'t? Statistics?

It appears that intestinal barrier function was assayed at 42d and no male \'smurfs\' were observed. However, in order to test the idea that male flies (of this strain) do not show barrier failure prior to death, a large number of older (70d as in other assays?) male flies should be examined. This is important because male flies of another laboratory strain (*w^1118^*) have been reported to show age-onset intestinal barrier dysfunction. See Rera et al. PNAS 2012 (Supp material). I appreciate that the authors are working with an outbred WT line and perhaps differences in age-onset pathology exist between lab strains. But, again, this earlier work (Rera PNAS 2012) should be cited in this context and discussed if indeed strain differences exist.

To be clear, the authors\' data supports the idea that male guts show a *delay* in the onset of \'gut pathology\'. But, if the authors wish to make the further/stronger claim that male flies, of their lab strain, do not show *any* (or negligible) age-onset gut pathology they need to provide more data.

The *Ecc* infection data is potentially interesting. But, I don\'t find the data compelling evidence that male flies show reduced tolerance to infection due to reduced \'gut plasticity\' as suggested in the abstract. There are a number of potential confounding factors that are not addressed:

1\) The flies were starved prior to the assay. This may lead to male/female differences in feeding. It is likely that male flies are more sensitive to starvation than females. Perhaps after a short period of starvation male flies eat more than females. If so, this would be a confounding factor, i.e. male flies are more sensitive to the *Ecc* infection because they take in more during the oral infection. Can the authors exclude this possibility?

2\) Also, it appears that the assay was carried out at 35d of age. As female flies live longer than males it is difficult to interpret this finding. 35d old females will likely be \'healthier\' than 35d old males. At 35 days of age, female flies will likely be more resistant to most extrinsic stressors, including stressors that do not act exclusively on the gut (e.g., heat, hyperoxia). Perhaps 35d old female flies have better immune function than 35d old males?

3\) In [Figure 2P](#fig2){ref-type="fig"}, it appears that male guts do show an ISC proliferation response to the infection. In fact, it could be argued that the magnitude of the male response is GREATER than that of the female response.

In summary, there are a number of reasons why at 35 days of age male flies are more sensitive to this infection. I would suggest that the authors are more careful not to overstate their findings and/or provide stronger evidence to support their claims.

Suggestions to improve impact

A potential role for the microbiota in sex differences in gut pathology is ignored. Several studies have reported that the presence of gut-associated microbes contributes to \'gut pathology\' in female flies. More specifically, axenic female flies show reduced \'gut pathology\' with age (Broderick et al., 2014, Buchon et al., 2009, Guo et al., 2014; Clark et al. 2015). This is, of course, what the authors claim to observe in the aging intestines of male flies. It would, therefore, be interesting to find out whether male flies show an age-related increase in bacterial load and/or microbial imbalance (dysbiosis) in the strains used in this study. If they do not, this may contribute to the delayed intestinal degeneration observed. I am not suggesting that this needs to be figured out in detail in the current manuscript. But, it is certainly worth investigating and could, potentially, provide insight. It would also be interesting and strengthen the claims if the authors could show that feminized male guts show alterations in the microbiota.

Reviewer \#3:

This manuscript by Regan et al. explores sex-specific differences in longevity and gut pathology with age in *Drosophila*. The relationship between lifespan and the gut\'s integrity and ability to respond challenges modulated by sex and age is largely unexplored in mechanistic detail, but is of significant general interest. The authors describe the phenomenon of sexual dimorphic gut phenotypes with age in some detail, but underlying mechanisms of the relationship remains to be elucidated. However, much of the conclusions are based on (not yet given) answers to points 1-3 below.

1\) Since the male gut maintains its integrity with age but live shorter the relationship to longevity is not clear, except that the superimposition of a \'feminization\' of the gut in a male body seems to make things worse.

2\) Given point 1, other measures of decline should be explored, such as oxidative stress, anti-microbial responsiveness (AMPs, etc.), proteostasis, etc., the authors allude to but do not consider, in order to provide additional direct (or inverse) correlates, other than ISC numbers. Regarding the latter, could the ISC number (or anti-microbial responsiveness) be directly reduced in the female gut or elevated in the male gut, other than (systemic) DR, that may have indirect effects?

3\) The high male vs female sensitivity of males to bacterial infection or DDT is interesting but insufficiently explored to be conclusive. Do ISC proliferate more, produce a higher anti-microbial response in females? What happens in young females, are they more susceptible? The discrepancy between susceptibility and gut integrity/permeability is puzzling and in a way counterintuitive, despite the speculation that higher ISC numbers may provide better potential repair (not demonstrated!). What is the progression of gut and other pathologies upon infection or DDT? Does the gut disintegrate more quickly in males with these challenges, or is the resulting morbidity unrelated to the gut?

4\) Controls are missing: Both driver and UAS controls should be provided for all experiments, not just one for longevity studies and the other for other experiments.

5\) The high-low yeast should be better explained in terms of concentration and how this relates to 1/2SYA in lifespan studies.

10.7554/eLife.10956.013

Author response

*1) More careful analysis of gut function breakdown during aging is required. While all reviewers agree with the analysis of ISC proliferation, more detailed and later timepoints need to be performed, especially in the case of male lifespan. Please consider Reviewer \#3's statements about other correlates.*

We have responded to this in some detail, including analysis of barrier function and pathology at older ages, AMP expression and ROS production over ageing. Also, the analysis of the age-dependent response to gut infection has been expanded as described below.

*2) Do the microbiota change in males vs. females, especially given the genetic alteration of male flies with a feminized gut. While it is agreed that a complete study of the microbiota is beyond the scope of this study, could a cursory analysis be completed to test if gross changes are observed? The same holds for dysbiosis.*

We have analyzed bacterial load over age, in males, females and feminized males, and the proportions of internal bacteria that can be cultured aerobically and anaerobically, providing some interesting new data.

*3) Data is provided for the lifespan effects on feminized guts of males, but infection by Ecc is not. Please test. Additionally, because this is a lifespan shortening effect, the authors need to control for strain sickness. One idea is to test another longevity paradigm that is not sex modified.*

We have analyzed the response to *Ecc* infection in males, females and feminized males, in some detail, including survival, induction of AMPs and ROS, and stem cell activity. To respond to the concern of strain sickness, we have investigated the effect of rapamycin treatment on gut pathology in both sexes and feminized males, and have further analyzed our existing lifespans with additional statistical tests.

*4) Throughout the text references are lacking or misplaced and prior work in this area is not discussed sufficiently.*

This has been dealt with and we feel that the references now better reflect the field.

*5) Appropriate driver controls for all experiments need to be presented.*

Appropriate controls for experiments have been added to the manuscript and included in new analyses.

*Reviewer \#1:\[...\] The issue of microbiota playing a role in males vs. females should be analyzed. Is there a huge difference and can this be reversed in the feminized males?*

We agree that identifying sex differences in the microbiota is interesting and informative. We have analysed internal bacterial load during ageing, and also the proportions of aerobic and anaerobic species, in males, females and feminized males. We found a higher bacterial load in females than in males at all ages examined. This correlates with the lower incidence (or lack of) of barrier dysfunction observed in *w^Dah^*males in this study. Strikingly, gut-feminized males had an increased load compared to both males and females. Internal bacterial load can thus be changed by feminization of gut tissue. In line with recent studies on females (Rera 2012, Guo 2014, Broderick 2014, Clark 2015) this increased bacterial load correlated with a high level of barrier dysfunction and systemic AMP expression in feminized males. This is now discussed in the manuscript. We also analyzed the proportions of aerobic and anaerobic species, an indication of the proportions of the two major genera (*Acetobacter* and *Lactobacilli*,), in 18 d and 40 d flies. We did not find significant differences in proportions either with ageing, or when comparing males, females and feminized males. A recent study by Clark et al. from the Walker lab demonstrated that changes in lower-abundance species, elucidated by deep sequencing of the microbiome, are important for age-related changes to the intestinal tissue in females. Our more general analysis will have missed subtle changes that could nevertheless have a significant impact on gut homeostasis. We have chosen not to present these data in the manuscript because we think that a much more detailed analysis would be required to draw any firm conclusions on sex differences in the composition of the microbiota and their potential impact.

*The lifespan analysis: showing that DR can make a sick strain more healthy is nice, but is it specific as stated? Is there a different lifespan extending paradigm that is not sex specific that can be tested? If so, does it increase longevity of the feminized animals?*

We are not sure what the question is here. If it is: 'DR makes healthy female flies live longer too, so can we be sure that it is the rescue of gut pathology that induces the response of lifespan to DR in the gut-feminized males? Given that the only sex reversal in these males is to a specific gut region, it must be ultimately responsible for the other phenotypes seen in these flies. To test whether the feminization results in a full, female-like, response of lifespan to DR we have performed Cox Proportional Hazard statistical analyses on three repeat measurements of the lifespans of gut-feminized males. This anlaysis showed that gut feminized males derived the same degree of lifespan extension as that seen in females. This finding supports the idea that the lifespans are being extended by the same mechanisms.

To probe the generality of the role of rescue of gut pathology in sex differences in response to lifespan-extending interventions, we analysed the guts of rapamycin-treated flies during ageing. Like DR, rapamycin extends lifespan in both males and females, but to a greater extent in females (Bjedov 2010). We find that epithelial pathology is delayed in rapamycin-treated females and, in addition, females have lower numbers of ISCs after treatment, in line with a recent study on rapamycin treatment and gut ageing (Fan 2015). Males do not derive an obvious change in gut maintenance or ISC proliferation with rapamycin treatment. Although we did not have time to analyse the lifespan of gut-feminized males on rapamycin, we have qualitatively analyzed gut pathology and quantified stem cell activity in these flies. Strikingly, ISC division is significantly reduced in females and feminized males, but not in males, after 2 weeks of rapamycin treatment. These new data show that, under another lifespan extending treatment (rapamycin) where males and females have a differential longevity response, the effect on gut maintenance is greater in females, who show a greater decline, and that this pathology is rescued in feminized males by the treatment. This further supports the idea that rescue of gut maintenance is a driver for extended lifespan in females and gut-feminized males.

*Some analysis of the feminized animals has been carefully performed. One piece lacking is the resistance to Ecc infection or other toxin (DDT) treatment. Are the feminized males now resistant?*

We agree that this is an important piece of information. We have subjected gut-feminized males to *Ecc* oral infection at young (7 d) and old (42 d) ages, and analysed survival and the ISC response. In young flies, only feminized males were sensitive to the infection. Females, males and feminized males all significantly increased mitoses after infection, but females had a far higher number of active ISCs per se. ISCs in feminized males proliferated more than in control males, but this was clearly not protective against the infection. In aged flies, in line with our data comparing males and females, only males died from *Ecc* infection. Feminized males were again the most susceptible to oral infection, dying sooner than both control male genotypes. Infected males had significantly more mitoses than sham infected individuals. Females, however, had a high number of mitoses, which did not increase significantly on infection. Similarly, feminized males did not increase ISC proliferation upon infection. One interpretation of this result is that in aged females and feminized males, the pool of ISCs has been exhausted by continued mitotic activity through the lifespan. Another is that, due to age-related triggers of stem cell activity such as inflammation or dysbiosis, stem cell activity is already at a maximum. These data show that age-related sensitivity of males to intestinal infection is not rescued by feminization of the midgut. One probable contributing factor to the high death rate of feminized males is their increased barrier dysfunction at old age (see below). However, their sensitivity to *Ecc* at 7 d points to other compromised immune responses. One possibility is that a sex mis-match between the gut and other tissues involved in the immune response to oral infection is detrimental.

*Reviewer \#2: In general, I find the paper and findings interesting. The physiological origins of sex differences in longevity are poorly understood. The major strength of the paper is the data showing that male flies with feminized guts show \'female-like\' pathology and show an improved lifespan response upon DR. My major concern, however, is that some of the claims of the paper are overstated and not fully supported by the data. Another issue regards the novelty of the findings and, perhaps more importantly, the authors not giving credit to previous work where credit is due. Major issues: Novelty: The Edgar lab reported in Cell. 2009 Jun 26;137([@bib7]):1343-55 that male guts show greatly reduced turnover rates compared to females. The Walker lab reported in PNAS 2012 109([@bib55]):21528-33 that diet restriction delays intestinal pathology in female flies.*

Both these studies are now cited. We consider that the novelty of the study is the thorough, new documentation of the sex difference in gut pathology during ageing, and the demonstration that by feminizing a region of the gut we can induce a response of gut pathology and lifespan to DR, thus explaining the sexually dimorphic response to this intervention. We also now present data suggesting that the same may be true of the sexually dimorphic response of lifespan to rapamycin.

*In the current manuscript, the authors build upon and extend both of these findings. But, they do not cite the preceding work. Citing the previous work doesn\'t harm the current paper. In fact, it strengthens the claims of the paper.*

We had missed both findings -- it was not a deliberate omission -- and in fact citing these papers strengthens the repeatability of aspects of our own study

*Claims of the paper not supported by the data: In both the Abstract and first line of the Discussion it is claimed that: Abstract: \"male flies die with their guts largely unaffected by ageing\"Discussion: \"male flies maintain a phenotypically perfect gut until death\".However, this claim is not supported by the data in paper. In order to support such a claim, the authors would need to examine gut pathology in a large number of male flies in the days (hours?) preceding death. Referring to [Figure 2](#fig2){ref-type="fig"}, in the text, the authors state that \'many\' male flies show no intestinal pathology up to 70d of age. I am missing this data. In the figures, I only see data up to 42 days of age. How many male flies were tested? What ages? How many 70d old male flies showed \'gut pathology\'? How many didn\'t? Statistics?*

We agree that analysis of very old flies is lacking from the manuscript and that claims of reduced/absent pathology should be supported by such data. To address this, we have included both qualitative and quantitative data on older male flies, at 64 d of age (which is approx. equal to the median lifespan of *w^Dah^* males). We agree that, because some males at old ages show the beginnings of gut pathology, it is more accurate to describe males as having a 'delayed' decline in gut structure. To clarify our findings, we have described in detail our categories for scoring pathology, and the difference between distinct gut regions. For example, at 64 d, the strongest sex bias we find is in the pathology of the PV, where females show a spectacular decline, whereas males show very little. In R2 and R4, around half of 64 d males show a 'prepathology'; that is sporadic, small clusters of stem cells/enteroblasts (category II). These do not have an effect on the overall epithelial structure, but precede the appearance of widespread small tumours (category III) and large tumours (category IV) that disrupt the integrity of the epithelium. A small percentage (\~10%) of males show a more significant pathology (category III). We never found large tumours (category IV) in males, in any gut region. We have also assessed the barrier function of males and females at 80 d, as described below.

*It appears that intestinal barrier function was assayed at 42d and no male \'smurfs\' were observed. However, in order to test the idea that male flies (of this strain) do not show barrier failure prior to death, a large number of older (70d as in other assays?) male flies should be examined. This is important because male flies of another laboratory strain (w^1118^) have been reported to show age-onset intestinal barrier dysfunction. See Rera* et al. *PNAS 2012 (Supp material). I appreciate that the authors are working with an outbred WT line and perhaps differences in age-onset pathology exist between lab strains. But, again, this earlier work (Rera PNAS 2012) should be cited in this context and discussed if indeed strain differences exist.*

We have looked for an onset of barrier dysfunction in male flies with age, by performing Smurf analyses at 80 d, in *w^Dah^* males and females. We find that, even in this oldest cohort, we never observe male Smurf flies appearing in this line. In parallel, we tested the *w^1118^* line for loss of barrier function, and we found that, similarly to the Walker lab (although at a lower rate than reported in Rera 2012), a small proportion of 42 d old males become Smurfs, although significantly fewer than females. Given the recent data from Clark 2015 demonstrating the tight link between microbiota and dysfunction, we find it unsurprising that different labs would observe differing Smurf rates. In addition, when we feminize male guts, a significant proportion show barrier dysfunction at 42 d, at a higher rate than control females. We think these data strengthen the idea that sex-specific rates of gut function decline exist and that barrier dysfunction, while being critical for female lifespan, may not be limiting to male lifespan.

*To be clear, the authors\' data supports the idea that male guts show a delay in the onset of \'gut pathology\'. But, if the authors wish to make the further/stronger claim that male flies, of their lab strain, do not show any (or negligible) age-onset gut pathology they need to provide more data.*

In addition to the new data described above, we have taken your advice and described male gut ageing more carefully.

*The Ecc infection data is potentially interesting. But, I don\'t find the data compelling evidence that male flies show reduced tolerance to infection due to reduced \'gut plasticity\' as suggested in the abstract. There are a number of potential confounding factors that are not addressed: 1) The flies were starved prior to the assay. This may lead to male/female differences in feeding. It is likely that male flies are more sensitive to starvation than females. Perhaps after a short period of starvation male flies eat more than females. If so, this would be a confounding factor, i.e. male flies are more sensitive to the Ecc infection because they take in more during the oral infection. Can the authors exclude this possibility?*

Good point. We have measured feeding rate of male, female and gut feminized male flies, on normal food (2 different yeast concentrations were included), and on starved, infected flies (fed bacterial pellet/sucrose or LB/sucrose) following the same feeding protocol as for infection survival assays. We found that on normal SYA food, males eat significantly less than females. Interestingly, gut-feminized feeding rates are the same as control males, suggesting that their feeding behavior is not changed in response to the feminization. Measuring rates on infected/sham-infected filters, we found that overall feeding was greatly reduced, compared to normal food, as expected. We did not see a significant difference between feeding rates in males, females or feminized males on either LB or *Ecc*, suggesting that feeding rate is not likely to be a confounding factor leading to greater male sensitivity. N.B. Considering this feeding data with respect to the Smurf assay: lower male feeding rates are not precluding males from showing the Smurf phenotype, as we observed a high number of Smurfs in the feminized males, despite their feeding rates being equal to control males on SYA.

*2) Also, it appears that the assay was carried out at 35d of age. As female flies live longer than males it is difficult to interpret this finding. 35d old females will likely be \'healthier\' than 35d old males. At 35 days of age, female flies will likely be more resistant to most extrinsic stressors, including stressors that do not act exclusively on the gut (e.g., heat, hyperoxia). Perhaps 35d old female flies have better immune function than 35d old males?*

We understand the concern that the healthspan of females and males are likely to be different given the differences in lifespan. However, we are wary of performing stress assays on older cohorts that have lost a significant proportion of flies, as what remains can be described as a 'selected population' that contains the healthier individuals, the weakest having been lost to early death. We have performed subsequent infections at 42 d, which represents an age where females already show significant gut pathology, but just precedes the steep decline on the male survival curve. We also agree that further analysis of the immune response in aged males and females would be informative, see below.

*3) In [Figure 2P](#fig2){ref-type="fig"}, it appears that male guts do show an ISC proliferation response to the infection. In fact, it could be argued that the magnitude of the male response is GREATER than that of the female response.*

As a proportion of basal levels, rather than numbers *per se*, male ISCs are indeed more responsive to infection. However, the rate per male gut is usually \<10. Although it has been shown that the ability of ISCs to respond to intestinal damage is important for survival (Buchon 2009, Chatterjee 2009), it is not known whether rate of division or total number of stem cells is important (and this may well be context-dependent). We have amended the discussion of this result accordingly.

*In summary, there are a number of reasons why at 35 days of age male flies are more sensitive to this infection. I would suggest that the authors are more careful not to overstate their findings and/or provide stronger evidence to support their claims.*

We strongly agree that sex differences in immune responses may be complex in origin and bear further investigation. We have performed two further experiments as described above: we have tested the resistance to *Ecc* oral infection in males, females and gut-feminized males (described above), and have performed qPCR for systemic *diptericin* (a gram negative responsive, IMD-pathway AMP) induction after *Ecc* oral infection, and *Duox*, which is expressed mainly in the gut epithelium after oral infection by uracil-releasing bacteria such as *Ecc*.

Systemic *diptericin* expression increases after infection in 42 d flies,but is induced at significantly higher levels in males than females. Males also show a high basal level of *diptericin* expression, indicative of systemic inflammation (see analysis inflammation during ageing, in response to Reviewer 3). Taken in context with the sensitivity of aged males to *Ecc* ingestion, high AMP expression may be an indicator of a worse outcome for males after oral infection. Gut feminized males show a high level of *diptericin* induction, in line with their reduced survival. This suggests that feminizing the gut does not feminize other aspects of the response to infection, such as AMP production by the fat body.

*Suggestions to improve impact A potential role for the microbiota in sex differences in gut pathology is ignored. Several studies have reported that the presence of gut-associated microbes contributes to \'gut pathology\' in female flies. More specifically, axenic female flies show reduced \'gut pathology\' with age (Broderick* et al.*, 2014, Buchon* et al.*, 2009, Guo* et al.*, 2014; Clark* et al. *2015). This is, of course, what the authors claim to observe in the aging intestines of male flies. It would, therefore, be interesting to find out whether male flies show an age-related increase in bacterial load and/or microbial imbalance (dysbiosis) in the strains used in this study. If they do not, this may contribute to the delayed intestinal degeneration observed. I am not suggesting that this needs to be figured out in detail in the current manuscript. But, it is certainly worth investigating and could, potentially, provide insight. It would also be interesting and strengthen the claims if the authors could show that feminized male guts show alterations in the microbiota.*

We have performed a preliminary analysis of microbiota during ageing in male, female and gut feminized flies, as described above in the response to Reviewer 1. We find that males of our *w^Dah^* line have a lower internal bacterial load than do females, and that this trend is reversed in feminized males. This is a very interesting preliminary observation, and we have included it in the manuscript.

However, this rather cursory analysis did not identify strong age-related changes in load (except in gut feminized males), or gross differences in the proportions of aerobic or anaerobic species. That is not to suggest that these features do not exist, and we may well have failed to detect subtle, but important differences between the sexes' microbiomes. Further study will need to take in to account both behavioral and physiological differences between males and females. Accordingly, we have been cautious in our discussion of these data. We suggest that this is an important and interesting arena for further investigation.

*Reviewer \#3: 1) Since the male gut maintains its integrity with age but live shorter the relationship to longevity is not clear, except that the superimposition of a \'feminization\' of the gut in a male body seems to make things worse.*

Given the broad body of work showing that gut decline has a direct relationship with female lifespan, and that male guts do not present the same decline, we hypothesize that intestinal dysfunction is not limiting to male lifespan. Of course, something else must be driving male mortality, and this is an open and interesting question. We agree that comparing other measures of decline will be informative, please see below.

*2) Given point 1, other measures of decline should be explored, such as oxidative stress, anti-microbial responsiveness (AMPs, etc.), proteostasis, etc., the authors allude to but do not consider, in order to provide additional direct (or inverse) correlates, other than ISC numbers.*

To assess other measures of decline (and in addition to *diptericin* induction on infection described above) we have measured *Dual oxidase (Duox*), a ROS producer and an indicator of oxidative stress, and systemic *diptericin (dipt*) expression in unchallenged males, females and gut-feminized males at young and old ages to get an idea of inflammatory status. We find that both males and females increase expression of *dipt* with age although, strikingly, males induce *dipt* at a significantly higher level than do females. In addition, males have a higher level of *Duox* expression than do females at young and old ages, likely reflecting intestinal ROS, because the gut is the major site of expression. This points to another intriguing sex bias in immune function, although we do not yet know how this correlates with the observed sex bias in gut decline, particularly given its inverse nature. We suggest sex differences in immunity uncovered here are not solely driven by decline of the gut epithelium given that, despite better barrier function, less gut pathology, lower ISC activity and lower bacterial load, males have high systemic inflammation and ROS and lower resistance to oral infection.

When we analysed systemic *diptericin* during ageing in gut feminized males, we found that expression levels were several fold higher than in control males and several orders of magnitude higher than in females, at both young and old age. This is in line with our findings that microbial load is increased in feminized males compared to males and females and that the gut barrier is compromised earlier than in females. But, as discussed above, we recognize that this may not be a straightforward correlation with gut maintenance, and have therefore been cautious in our discussion.

*Regarding the latter, could the ISC number (or anti-microbial responsiveness) be directly reduced in the female gut or elevated in the male gut, other than (systemic) DR, that may have indirect effects?*

Several studies have manipulated ISC number directly in female guts by gut-specific expression of; a dominant-negative version of the Insulin Receptor, JAK-STAT signalling, and PGC-1, and have increased female lifespan as a result (Biteau 2010, Rera 2011, Ulgherait et al. 2014 and others). We agree that manipulation by another paradigm would strengthen the connection between gut decline and lifespan in both sexes. We have included data from rapamycin treated *Resille-GFP* flies (see response to Reviewer 1), demonstrating a sex bias in the effect on gut pathology/ISC number. Although we recognize that this is also a systemic treatment, the fact that female (and feminized male) gut pathology responds to the treatment supports the idea that rescue of gut maintenance is a driver for extended lifespan in females (and gut-feminized males), but is less important for males.

*3) The high male vs female sensitivity of males to bacterial infection or DDT is interesting but insufficiently explored to be conclusive. Do ISC proliferate more, produce a higher anti-microbial response in females? What happens in young females, are they more susceptible? The discrepancy between susceptibility and gut integrity/permeability is puzzling and in a way counterintuitive, despite the speculation that higher ISC numbers may provide better potential repair (not demonstrated!). What is the progression of gut and other pathologies upon infection or DDT? Does the gut disintegrate more quickly in males with these challenges, or is the resulting morbidity unrelated to the gut?*

We agree that further analysis of this phenotype is important. We have expanded our analysis of the response to oral *Ecc* infection as described in detail above. Females are resistant to *Ecc* infection at young and old ages, induce a high level of ISC proliferation in response to infection (although this is overlaid on a high basal level of activity in old guts), but do not induce a significant systemic AMP response, perhaps suggesting that they have effectively dealt with the infection at the level of the gut. Males increase ISC proliferation, but nevertheless succumb to oral infection at older ages, with a high and variable systemic induction of *diptericin.* Feminized males induce ISC proliferation to a similar level as females, but induce high systemic AMPs like males, and the infection is fatal.

This suggests that the hypothesis we offered, that the observed sex bias is driven by different rates of repair, was over-simplistic, and we have modified the discussion to reflect this. ISC-driven repair has been demonstrated to be required for survival to oral infection in females (Buchon 2009, Chatterjee 2009), however, several other parameters will affect male and female ability to resist infection, including; barrier function at the time of bacterial ingestion, specific bacterial and viral load, basal and induced AMP and *Duox* release and tolerance mechanisms.

*Ecc* ingestion is not usually lethal to healthy female adults (this study, Ha 2005, Regan 2013), and this is true, even at older ages, despite barrier dysfunction in a subset of females demonstrated by the Smurf assay. We agree that this is counter-intuitive, and suggest that a leaky gut barrier is not a driver of mortality in the context of *Ecc* infection in females (although it may well be important in the face of more virulent infections, or in the interaction of the ageing fly with its microbiota).

*4) Controls are missing: Both driver and UAS controls should be provided for all experiments, not just one for longevity studies and the other for other experiments.*

We have added both driver and UAS controls to the manuscript. They were already included in all lifespans (which are particularly sensitive to polygenic effects), and are now presented fully. Both controls have been provided for all other subsequent analyses, except in the cases where the experiment required a large amount of dissection within a small time window, such as ISC analysis after 18h infection. To address this, we have compared ISC activity over ageing in our two control lines, and find no difference between them (this is now presented in the manuscript).

*5) The high-low yeast should be better explained in terms of concentration and how this relates to 1/2SYA in lifespan studies.*

We have amended the text and the figures to make the feeding regime clear. 'High' (2SYA) and 'low' (1SYA) are equivalent to 1:2 ratio of sugar to yeast and 1:1 sugar to yeast, respectively. An extra sentence has been added to the Methods section to clarify this.

In summary, we feel that the additional data presented here strengthens the study and we thank the reviewers for their comments and suggestions for further work. We have shown that the males and females differ in the pathology of the ageing gut, at least partly driven by sex-biased stem cell activity, and female intestinal decline can be recapitulated in the male gut by tissue-autonomous sex-switching. Lessening of this pathology extends lifespan in females but it may not be a significant driver of male mortality. Feminization of gut cells increases bacterial load, induces gut pathology, shortens male lifespan and induces plasticity to DR, but does not make males more robust to intestinal infection. Aged males succumb to an oral infection that females are resistant to, and induce high levels of inflammatory AMPs and ROS over ageing, raising the intriguing possibility that other sex-biased immune processes are important for male mortality.
